上海凯宝(300039) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was CNY 475,496,607.80, representing a 3.51% increase compared to CNY 459,387,490.40 in the same period last year[5]. - Net profit attributable to shareholders was CNY 88,458,934.18, up 10.33% from CNY 80,178,876.36 year-on-year[5]. - Total operating revenue for Q1 2024 was CNY 475.50 million, an increase of 3.4% compared to CNY 459.39 million in Q1 2023[23]. - Net profit for Q1 2024 reached CNY 88.30 million, representing a 10.3% increase from CNY 80.12 million in Q1 2023[24]. - Basic and diluted earnings per share for Q1 2024 were CNY 0.0846, up from CNY 0.0767 in Q1 2023, reflecting a growth of 10.3%[25]. - The total comprehensive income for Q1 2024 was CNY -253.16 million, contrasting with CNY 353.83 million in Q1 2023, showing a substantial decrease[25]. Cash Flow and Liquidity - The net cash flow from operating activities decreased by 8.03% to CNY 72,941,777.87 from CNY 79,310,976.85 in the previous year[5]. - Cash inflow from operating activities was CNY 499.97 million in Q1 2024, compared to CNY 485.00 million in Q1 2023, an increase of 3.1%[27]. - The total cash outflow from operating activities amounted to ¥427,029,427.57, an increase of 5.9% from ¥405,690,723.95 in the previous year[28]. - The company reported a net increase in cash and cash equivalents of ¥102,750,141.85, compared to a net increase of ¥267,676,502.29 in Q1 2023[28]. - Cash and cash equivalents saw a net increase of 61.61% year-on-year, indicating improved liquidity despite higher cash outflows from investment activities[10]. - The ending balance of cash and cash equivalents was ¥538,504,327.47, down from ¥582,156,672.45 at the end of Q1 2023[28]. Assets and Liabilities - Total assets decreased by 6.39% to CNY 4,286,989,459.15 from CNY 4,579,672,915.20 at the end of the previous year[5]. - The total liabilities decreased to CNY 507.29 million in Q1 2024 from CNY 546.82 million in Q1 2023, a reduction of 7.2%[21]. - The total equity attributable to shareholders of the parent company was CNY 3.78 billion in Q1 2024, down from CNY 4.03 billion in Q1 2023, a decline of 6.3%[21]. - The company experienced a 46.26% increase in accounts payable, primarily due to rising costs of raw materials[9]. - Accounts receivable decreased to RMB 348,479,000.04 from RMB 370,363,547.94, a decline of approximately 5.9%[19]. - Inventory decreased to RMB 159,194,089.89 from RMB 171,793,487.67, reflecting a reduction of about 7.4%[20]. Research and Development - R&D expenses increased by 34.50% compared to the same period last year, indicating a significant investment in new projects[9]. - Research and development expenses increased to CNY 32.38 million in Q1 2024, compared to CNY 24.08 million in Q1 2023, marking a 34.6% rise[24]. - The company has not reported any new product launches or technological advancements in this quarter, indicating a potential area for future development[17]. Strategic Initiatives - The company plans to invest RMB 1.212 billion in a modern Chinese medicine intelligent manufacturing project, acquiring land use rights for 69,196.49 square meters[17]. - The company’s financial performance and strategic initiatives will be closely monitored in the upcoming quarters to assess growth potential and market positioning[17]. - The company continues to focus on maintaining liquidity and managing cash flows effectively amid changing market conditions[28]. Other Financial Metrics - The weighted average return on equity dropped to -6.48% from 8.98% year-on-year, reflecting a decline in profitability[5]. - The company reported a 39.21% decrease in investment income compared to the previous year, primarily due to reduced returns from financial products[9]. - Other comprehensive income after tax for Q1 2024 was CNY -341.46 million, compared to CNY 273.71 million in Q1 2023, indicating a significant decline[24]. - The company did not report any cash inflow or outflow from financing activities during the quarter[28]. - The company has not undergone an audit for the Q1 2024 report[30]. - The report is the first to apply the new accounting standards starting from 2024[29].